| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169814 Guanidinium transport reagents and conjugates |
| 01/30/2007 | US7169808 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | US7169761 Azulene derivatives and salts thereof |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169607 In vivo induction for enhanced function of isolated hepatocytes |
| 01/30/2007 | US7169581 IL-18 receptors |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169407 Carbonyl stress-decreasing agent |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2411153C Method for preparing a composition |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2185794C Agent for relieving side effects caused by immunosuppressants |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/30/2007 | CA2154098C Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/25/2007 | WO2007011563A1 Derivatives of seleno-amino acids |
| 01/25/2007 | WO2007011072A1 Premature ovulation preventive agent |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010964A1 Indole derivative having pgd2 receptor antagonist activity |
| 01/25/2007 | WO2007010946A1 Synovial cell proliferation inhibitor |
| 01/25/2007 | WO2007009393A1 The use of chlorogenic acid in the manufacture of medicaments for increasing the effect of bone marrow cells |
| 01/25/2007 | WO2006119168A3 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 01/25/2007 | WO2006112961A3 Synergistic salivation components |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021462 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021461 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021437 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021391 Preventive/remedy for urinary disturbance |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021381 Stabilizing the mutant enzyme by administering a reversible competitive inhibitor consisting an iminosugar, 4-epi-isofagomine or 1-deoxygalactonojirimycin; Gaucher's disease; lysosomal storage diseases |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070020694 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 01/25/2007 | US20070020384 Environmentally benign crop protection agents |
| 01/25/2007 | US20070020309 Safe and effective biofilm inhibitory compounds and health related uses thereof |
| 01/25/2007 | US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | CA2615795A1 Premature ovulation preventive agent |
| 01/25/2007 | CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/25/2007 | CA2615231A1 Prevention and treatment of ophthalmic complications of diabetes |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745801A1 Method of inhibiting telomerase activity and inhibitor |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745790A2 Treatment of rumen acidosis with alpha-amylase inhibitors |
| 01/24/2007 | EP1745789A1 Compositions comprising ribose for increasing energy in vivo |
| 01/24/2007 | EP1745788A1 Acyglycerophospholipids for treating cancer and cachexia |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/24/2007 | EP1745785A1 Pharmaceutical composition for preventing or treating cerebral oedema |
| 01/24/2007 | EP1745774A2 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
| 01/24/2007 | EP1744773A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus |
| 01/24/2007 | EP1744745A1 Pharmaceutical nitrones |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1443967B1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 01/24/2007 | EP1423100B1 Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails |
| 01/24/2007 | EP1408964B1 Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts |
| 01/24/2007 | EP1408939A4 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1309591B1 Substituted pyrazoles |
| 01/24/2007 | EP1280531B1 Formulation consisting of phentolamine mesylate and the use thereof |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | EP1174151B1 Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient |